UCB SA Website

UCB SA

ENXTBR-UCB

Basic

  • Market Cap

    €28.53B

  • EV

    €31.14B

  • Shares Out

    189.72M

  • Revenue

    €5,454M

  • Employees

    8,767

Margins

  • Gross

    67.8%

  • EBITDA

    21.73%

  • Operating

    9%

  • Pre-Tax

    5.24%

  • Net

    4.4%

  • FCF

    12.1%

Returns (5Yr Avg)

  • ROA

    5.55%

  • ROTA

    14.57%

  • ROE

    9.6%

  • ROCE

    9.63%

  • ROIC

    8.06%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    €142.86

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    €428M

  • Net Debt

    €2,610M

  • Debt/Equity

    0.34

  • EBIT/Interest

    3.09

Growth (CAGR)

  • Rev 3Yr

    -0.38%

  • Rev 5Yr

    3.08%

  • Rev 10Yr

    5.93%

  • Dil EPS 3Yr

    -36.85%

  • Dil EPS 5Yr

    -19.03%

  • Dil EPS 10Yr

    -0.28%

  • Rev Fwd 2Yr

    10.68%

  • EBITDA Fwd 2Yr

    19.92%

  • EPS Fwd 2Yr

    27.29%

  • EPS LT Growth Est

    7.5%

Dividends

  • Yield

    —

  • Payout

    107.67%

  • DPS

    €1.36

  • DPS Growth 3Yr

    2.31%

  • DPS Growth 5Yr

    2.36%

  • DPS Growth 10Yr

    2.72%

  • DPS Growth Fwd 2Yr

    3.04%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Operating Revenues

4,758

5,148

5,550

5,225

4,944

5,208

Other Revenues, Total

155

199

227

222

238

246

Total Revenues

4,913

5,347

5,777

5,447

5,182

5,454

Total Revenues % Chg.

6.1%

8.8%

8%

-5.7%

-4.9%

3.3%

Cost of Goods Sold, Total

1,268

1,363

1,438

1,674

1,707

1,756

Gross Profit

3,645

3,984

4,339

3,773

3,475

3,698

Selling General & Admin Expenses, Total

1,303

1,417

1,554

1,714

1,824

2,033

R&D Expenses

1,272

1,569

1,629

1,670

1,630

1,660

Other Operating Expenses

-41

-38

-158

-210

-557

-486

Other Operating Expenses, Total

2,534

2,948

3,025

3,174

2,897

3,207

Operating Income

1,111

1,036

1,314

599

578

491

Interest Expense, Total

-60

-68

-45

-72

-144

-159

Interest And Investment Income

17

14

9

12

30

29

Net Interest Expenses

-43

-54

-36

-60

-114

-130

Income (Loss) On Equity Invest.

—

—

—

—

-1

2

—

—

—

—

Currency Exchange Gains (Loss)

-58

-38

-19

-7

-37

-19

Other Non Operating Income (Expenses)

-5

-1

-4

-5

-12

-12

EBT, Excl. Unusual Items

1,004

945

1,255

527

415

330

Restructuring Charges

-47

-20

-21

-42

-13

-13

Merger & Related Restructuring Charges

—

—

—

—

—

-95

—

-41

—

—

Gain (Loss) On Sale Of Investments

—

—

—

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

48

50

-3

71

-26

-26

Asset Writedown

—

-2

—

-6

-2

-5

-5

Other Unusual Items

-42

—

—

-2

70

—

EBT, Incl. Unusual Items

961

880

1,225

511

441

286

Income Tax Expense

146

119

170

91

98

46

Earnings From Continuing Operations

815

761

1,055

420

343

240

Earnings Of Discontinued Operations

2

—

3

-2

—

—

Minority Interest

-25

-29

—

—

—

—

Net Income

792

732

1,058

418

343

240

Net Income to Common Incl Extra Items

792

732

1,058

418

343

240

Net Income to Common Excl. Extra Items

790

732

1,055

420

343

240

Total Shares Outstanding

188.6

189

189.2

189.6

189.8

189.7

Weighted Avg. Shares Outstanding

187.2

189

189

189.6

189.7

190

Weighted Avg. Shares Outstanding Dil

193

194.2

194.2

194.8

195.2

195.3

EPS

4.2

3.9

5.6

2.2

1.8

1.3

EPS Diluted

4.1

3.8

5.5

2.1

1.8

1.2

EBITDA

1,380

1,342

1,593

1,138

1,269

1,185

Effective Tax Rate

15.2%

13.5%

13.9%

17.8%

22.2%

16.1%